Review and inventory of 911 Good Samaritan Law Provisions in the United States

Int J Drug Policy. 2022 Dec:110:103896. doi: 10.1016/j.drugpo.2022.103896. Epub 2022 Nov 4.

Abstract

Background: 911 Good Samaritan Laws (GSLs) confer limited legal immunity to bystanders in possession of controlled substances who report emergency overdoses. While these laws may decrease opioid overdose mortality, current literature reduces GSLs to a small number of variables, overlooking substantial differences in implementation and statutory context which dramatically alter their applicability.

Methods: We identified all state GSLs and their legislative history, characterizing features into four categories using a novel framework: breadth of protected activities, burden placed on Good Samaritans, strength of protection, and exemption in coverage. When protections depended on the nature of the controlled substance, heroin served as a common point of comparison.

Results: GSLs vary substantially across states and time. Protections depend on the quantity of substances involved and may extend to the person experiencing the overdose or persons reporting their own overdose. Protected offenses range from possession of controlled substances to drug-induced homicide. In some states, Good Samaritans must complete substance use treatment or administer naloxone to retain protections. Immunity ranges from protection from arrest to merely procedural protections at trial, and may even exclude persons in possession of opioids. Exemptions target persons engaging in chronic substance use, such as persons invoking protection multiple times or previously reporting an overdose.

Conclusion: States offer Good Samaritans substantially different protections even when the statutes confer nominally comparable immunities. Accommodating this heterogeneity will enhance the validity of future studies into these laws and their efficacy.

Keywords: Good Samaritan; Harm reduction; Opioids; Overdose; State policy.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid
  • Controlled Substances*
  • Drug Overdose* / drug therapy
  • Drug Overdose* / prevention & control
  • Humans
  • Law Enforcement
  • Naloxone / therapeutic use
  • Narcotic Antagonists / therapeutic use
  • United States

Substances

  • Controlled Substances
  • Naloxone
  • Analgesics, Opioid
  • Narcotic Antagonists